-
Calls for Leadership Stability and Rare Disease Follow-Through at FDA in 2026
05 Jan 2026 05:58 GMT
… development of experimental treatments for diseases affecting … trial—as opposed to the usual two—for new drug … the domestic supply chain. Augmentin XR, for example, … FDA,” particularly given his vaccine skepticism and “aggressive stance” against pharmaceutical …
-
After splash in 2025, weight-loss drugs poised to take off this year
03 Jan 2026 01:46 GMT
… 1 weight-loss drugs, a new class of medications, entered the … pharmaceutical market by value, ranking just behind GSK’s antibiotic Augmentin … expensive, long-term metabolic treatment. That willingness has turned … in a Phase 3 trial.
Story continues below this …
-
I thought I had cancer but my recurring, agonising UTIs were caused by a far more common problem that affects all women... and this is the simple fix doctors rarely offer
01 Jan 2026 14:28 GMT
… cranberry juice and a powder remedy made from cranberries, which … a motorway to see a doctor to get a prescription. … told more expensive) antibiotic called Augmentin. It worked in just … it.’
However, he adds: ’Alternative treatments are important as we really …
-
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report
18 Dec 2025 14:44 GMT
… cholesterol-lowering pill enlicitide decanoate and the antibody-drug conjugate (ADC … in two Phase III trials in June, BMO Capital … New England Journal of Medicine, showed the ADC cut … amoxicillin formulation Augmetin XR. Augmentin XR was approved earlier this …
-
<![CDATA[Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher]]>
17 Dec 2025 02:48 GMT
… voucher. When a treatment demonstrates outstanding trial results, we have … Johnson & Johnson Innovative Medicine, said in a press … a critical drug for general anesthesia
Augmentin XR for … 2025.
5. Doctors for America. FDA Commissioner’s National Priority …
-
<![CDATA[FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma]]>
15 Dec 2025 21:47 GMT
… potentially transformative therapies,” said FDA Commissioner Marty Makary, MD … voucher. When a treatment demonstrates outstanding trial results, we … & Johnson Innovative Medicine, said in a press … a critical drug for general anesthesia
Augmentin XR for …
-
We must stay vigilant on false patent extensions and the non-clinical use of weight-loss drugs
16 Dec 2025 08:08 GMT
… brand of another weight-loss drug called tirzepatide, was launched this … GlaxoSmithKline’s antibiotic Augmentin as India’s largest selling medicine by value … . This reveals huge demand for drugs that promise to help people …
-
J&J Wins Proactive FDA National Priority Voucher for Multiple Myeloma Combo
16 Dec 2025 14:56 GMT
…
“When a treatment demonstrates outstanding trial results, we have … and Revolution Medicines’ oral cancer drug RMC-6236 … USAntibiotics’ amoxicillin formulation Augmentin XR, won the … candidate orforglipron. Vertex Pharmaceuticals and CRISPR Therapeutics’ …
-
FDA Approves Augmentin XR Antibiotic as Part of National Priority Voucher Pilot Program
15 Dec 2025 19:48 GMT
… medicines while advancing public health and national security.
The US FDA approved Augmentin … for active pharmaceutical ingredients and … consequences, including treatment delays and increased … featuring experts in drug substance, drug product, manufacturing …
-
<![CDATA[FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis]]>
13 Dec 2025 00:23 GMT
… the first drug to be approved via FDA’s … clavulanate, Augmentin XR is an oral antibacterial medication indicated for … both adult and pediatric patients, for treatment … for review (4).
Pharmaceutical Technology® provided an in …